AU2003270424A1 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents
Therapeutic polypeptides, nucleic acids encoding same, and methods of useInfo
- Publication number
- AU2003270424A1 AU2003270424A1 AU2003270424A AU2003270424A AU2003270424A1 AU 2003270424 A1 AU2003270424 A1 AU 2003270424A1 AU 2003270424 A AU2003270424 A AU 2003270424A AU 2003270424 A AU2003270424 A AU 2003270424A AU 2003270424 A1 AU2003270424 A1 AU 2003270424A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- nucleic acids
- acids encoding
- encoding same
- therapeutic polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40914502P | 2002-09-09 | 2002-09-09 | |
US60/409,145 | 2002-09-09 | ||
US40954402P | 2002-09-10 | 2002-09-10 | |
US60/409,544 | 2002-09-10 | ||
US41032002P | 2002-09-12 | 2002-09-12 | |
US60/410,320 | 2002-09-12 | ||
US41106002P | 2002-09-16 | 2002-09-16 | |
US60/411,060 | 2002-09-16 | ||
US41276602P | 2002-09-23 | 2002-09-23 | |
US41282502P | 2002-09-23 | 2002-09-23 | |
US60/412,766 | 2002-09-23 | ||
US60/412,825 | 2002-09-23 | ||
US41334202P | 2002-09-24 | 2002-09-24 | |
US41276702P | 2002-09-24 | 2002-09-24 | |
US60/412,767 | 2002-09-24 | ||
US60/413,342 | 2002-09-25 | ||
US41483202P | 2002-09-30 | 2002-09-30 | |
US60/414,832 | 2002-09-30 | ||
PCT/US2003/028141 WO2004022723A2 (fr) | 2002-09-09 | 2003-09-09 | Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003270424A1 true AU2003270424A1 (en) | 2004-03-29 |
AU2003270424A8 AU2003270424A8 (en) | 2004-03-29 |
Family
ID=31982838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003270424A Abandoned AU2003270424A1 (en) | 2002-09-09 | 2003-09-09 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003270424A1 (fr) |
WO (1) | WO2004022723A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006065582A2 (fr) * | 2004-12-14 | 2006-06-22 | Eli Lilly And Company | Muteines du facteur de croissance fibroblastique 21 |
WO2008153705A2 (fr) * | 2007-05-22 | 2008-12-18 | Novartis Ag | Procédés de traitement, de diagnostic et de détection de troubles liés à fgf21 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6326472B1 (en) * | 1997-10-15 | 2001-12-04 | Schering Corporation | Human receptor proteins; related reagents and methods |
-
2003
- 2003-09-09 WO PCT/US2003/028141 patent/WO2004022723A2/fr active Search and Examination
- 2003-09-09 AU AU2003270424A patent/AU2003270424A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004022723A2 (fr) | 2004-03-18 |
AU2003270424A8 (en) | 2004-03-29 |
WO2004022723A3 (fr) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003023008A8 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes | |
EP1576169A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees | |
AU2003226416A1 (en) | Polypeptides having xyloglucanase activity and nucleic acids encoding same | |
AU2002356534A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1487864A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees | |
AU2003217956A1 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
EP1446419A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation | |
EP1432726A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes | |
EP1401858A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
WO2003040330A8 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant | |
EP1695078A4 (fr) | Polypeptides de metadherine codant des acides nucleiques et procedes d'utilisation | |
EP1532238A4 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant | |
AU2003247537A1 (en) | Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof | |
WO2003083039A8 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et leurs procedes d'utilisation | |
EP1549671A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees | |
AU2002334781A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
EP1399537A4 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation | |
AU2002309646A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
WO2003060149A9 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
AU2003304034A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003270424A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2002365216A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003023002A9 (fr) | Nouvelles proteines humaines, polynucleotides codant ces proteines et procedes d'utilisation associes | |
AU2003282764A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003219743A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |